To determine the influence of anxiety on the progression of disability and examine possible mediators of the relationship. DESIGN: Community-based observational study. SETTING: Women's Health and Aging Study I, a prospective observational study with assessments every 6 months for 3 years. PARTICIPANTS: One thousand two functionally limited women aged 65 and older. MEASUREMENTS: Anxiety symptoms were assessed using four questions from the Hopkins Symptom Checklist (nervous or shaky, avoidance of certain things, tense or keyed up, fearful). Participants who reported experiencing two or more of these symptoms at baseline were considered anxious. Anxiety as a predictor of the onset of four types of disability was examined using Cox proportional hazards models. Three models were tested: an unadjusted model, a model adjusted for confounding variables (age, race, vision, number of diseases, physical performance, depressive symptoms), and a mediational model (benzodiazepine and psychotropic medication use, physical activity, emotional support). RESULTS: Nineteen percent of women reported two or more symptoms of anxiety at baseline. Unadjusted models indicate that anxiety was associated with a greater risk of worsening disability: activity of daily living (ADL) disability (relative risk (RR) 5 1.40, 95% confidence interval (CI) 5 1.10-1.79), mobility disability (RR 5 1.41, 95%
T he effects of anxiety extend beyond that of emotional functioning. Evidence suggests that anxiety is associated with functional limitations or ''a restriction in or lack of ability to perform an activity because of impairment.'' 1 Previous work on the relationship between anxiety and role functioning has excluded older adults and has largely focused on interference with work functioning. A number of studies in younger samples have demonstrated that anxiety and work disability (e.g., days of work missed due to anxiety) are indeed related. [2] [3] [4] [5] [6] The potential effect of anxiety on functioning or difficulty performing activities of daily living (ADLs) and instrumental ADLs in older adults has rarely been considered. Only a few studies have examined these relationships, and most were cross-sectional, precluding the examination of anxiety as a precipitating factor. A study of 61 women with osteoarthritis of the knee indicated that anxiety was significantly correlated with performance difficulty and activity limitation, even after statistically controlling for radiographic disease severity. 7 More recently, it was demonstrated that anxiety was correlated with ADL disability in older adults who had sustained a stroke or broken hip. 8 Another study showed that anxiety was associated with increased physical disability in a sample of older adults after statistically controlling for a number of variables, including the number of chronic diseases and functional limitations.
Only two longitudinal studies were identified that examined anxiety as a predictor of physical disability. One found that anxiety was a significant predictor of ADL disability over a 1-year period after controlling for baseline physical functioning. 10 The other followed 198 patients with coronary artery disease and also found that anxiety was predictive of functional disability. 11 Limitations of these studies are that participants with disability at baseline were not excluded from the analyses and that there was a lack of control for baseline level of physical functioning.
Three variables may explain the relationship between anxiety and disability: physical activity, benzodiazepine and psychotropic medication use, and lack of emotional support. Anxiety may cause people to be less physically active, thereby causing disability. 12, 13 Another possibility is that people with anxiety are more likely to be medicated with benzodiazepines, which has been linked to a number of adverse health outcomes in older people, including declines in functional status, falls, and hip fractures. 14, 15 Finally, lack of emotional support, which may promote anxiety, has been linked to disability in older adults. 16 The purpose of this study was to examine the effect of anxiety on the progression of disability over 3 years in a large sample of vulnerable older women. The role of physical activity, benzodiazepine and psychotropic medication use, and emotional support as mediators of this relationship were also examined.
METHODS

Study Population
Data are from the Women's Health and Aging Study I, a 3-year longitudinal study of the causes and course of disability in the one-third-most-disabled older women living in the community. 17 An age-stratified random sampling of Medicare beneficiaries in Baltimore, Maryland, was undertaken to identify participants. A total of 5,316 women were eligible for screening, and 81% were screened. Of these, 1,409 were eligible for the study, and 1,002 agreed to participate. All participants were women aged 65 and older who had difficulty in at least two of the following domains: mobility or exercise tolerance (e.g., walking one-quarter of a mile), upper extremity ability (e.g., raising arms over head), higher functioning tasks (e.g., using the telephone), or basic self-care (e.g., bathing). Participants who were cognitively impaired, as indicated by a Mini-Mental State Examinaton 18 score less than 18, were excluded. All participants were interviewed and examined by trained, certified personnel administering standardized protocols and questionnaires in their home every 6 months over the course of 3 years. The institutional review board of Johns Hopkins University School of Medicine and the U.S. Office of Management and Budget approved this study; all participants provided written informed consent at enrollment.
Measures
Demographics
Demographic information, including age, race (white, not white), marital status (married, not married), and years of education, was obtained.
Anxiety Anxiety symptoms were assessed using four questions from the Hopkins Symptom Checklist. 19 Participants indicated whether they felt nervous or shaky, avoided certain things, felt tense or keyed up, or felt fearful. These four symptoms were chosen because they are characteristic of most anxiety disorders. Women who reported that they experienced two or more of these symptoms of anxiety quite a bit or extremely frequently over the previous week were considered to have anxiety. Anxiety symptoms tend to be stable in this sample. For instance, 54% of participants who reported anxiety symptoms at baseline also reported anxiety symptoms at the 6-month follow-up.
Depression
Depression was assessed using the Geriatric Depression Scale. 20 Responses to the 30 items were summed, and women who scored 10 or greater were considered to have high depressive symptoms.
Disability
To capture a full range of severity and effect on function, disability in four areas was assessed. Participants were asked to rate their difficulty in performing ADLs (bathing, dressing, eating, transferring from bed to chair, using the toilet), walking across a room, lifting 10 pounds, and performing light housework (such as doing dishes, straightening up, or light cleaning). Responses were ''a little difficulty,'' ''some difficulty,'' ''a lot of difficulty,'' and ''unable to do it.'' Consistent with previous studies, disability was considered present if the participant reported ''a lot of difficulty'' or inability to perform a task.
22,25
Health-Related Characteristics The presence of 17 major chronic conditions was determined using standardized algorithms that incorporated participant self-report of physician diagnosis and of symptoms, physical examination findings, medications used, physician reports, and review of medical records. 26 A variable representing the number of validated diseases that were present was then created. The presence of visual impairment was assessed by asking the women whether they could see well enough to watch television, read a newspaper, or recognize someone across the room. The presence of a hearing problem was assessed by asking the women whether they could hear well enough to use the telephone or to carry on a conversation in a crowded room.
Physical Performance
To adjust for baseline physical function, performance was assessed using the Short Physical Performance Battery, which consists of walking 4 m, standing up from and sitting down in a chair five times, and three sequential standing balance tests. Participants received a score from 0 (unable to perform) to 4 (best performance) on each test, based on scoring criteria from the Established Populations for Epidemiologic Studies of the Elderly. 27 Scores on each test were summed to create a summary measure of physical performance that ranged from 0 to 12, with higher scores indicating better performance.
Possible Mediators
Three mediating variables that could potentially help explain the link between anxiety and disability were examined: benzodiazepine and psychotropic medication use, physical activity, and emotional support. During the interviews, participants displayed all the medications (prescription and over the counter) they had used within the previous 2 weeks, and all medications used by participants were recorded. Interviewers transcribed the names and dosages of all medications. This method of medication ascertainment is similar to that used in other large epidemiological studies and has been shown to be reliable and valid. 28 For this report, a dichotomous variable (yes/no) represented the use of benzodiazepines and psychotropic medications. Physical activity was assessed by asking participants how many blocks they had walked during the previous week. A median split was performed; responses are represented by a dichotomous variable (o5 blocks/ ! 5 blocks). Emotional support was assessed by asking participants whether they could have used more emotional support than they received in the previous year (yes/no).
Statistical Analyses
A two-step process was used to examine the relationship between anxiety and the progression of disability. To determine characteristics associated with baseline anxiety, bivariate relationships between anxiety and baseline demographics, health-related characteristics, and physical functioning were tested using t tests or chi-square (w 2 ) analyses. Variables that were significantly related to baseline anxiety were entered as covariates in regression analyses. In the second step, a series of proportional hazards models using Cox regression analyses were conducted. Dependent variables included the time to onset of disability in each of the four areas: ADLs, mobility, lifting, and light housework. Only participants who reported no disability at baseline in a particular area were included in the analyses, and the first report of disability was considered the event of incident disability, regardless of the participant's status at subsequent interviews. Individuals who died or were lost to follow-up were censored after their last interview. Participants who survived with no evidence of progression of disability were censored at 3 years. Model 1 presents baseline anxiety as a predictor of worsening disability. In Model 2, age, race, vision problems, number of diseases, objective physical performance, and depression were entered as covariates. In Model 3, benzodiazepine and psychotropic medication use, physical activity, and emotional support were added to the regression analyses to determine whether they were mediators of the effects of anxiety on disability.
RESULTS
The Women's Health and Aging Study (WHAS) sample consisted of 1,002 disabled older women with an average age AE standard deviation of 78.3 AE 8.1. All women had at least two disabilities at baseline; 33.0% had an ADL disability, 16.0% had a mobility disability, 35.1% had a lifting disability, and 17.1% had a light housework disability. Nineteen percent of the sample reported two or more symptoms of anxiety at baseline. As shown in Table 1 , anxiety symptoms were associated with race, vision, number of diseases, baseline physical performance, and depressive symptoms. White race (P 5.04), vision problems (P 5.03), greater comorbidity (P 5.01), poorer physical performance (Po.001), and depressive symptoms (Po.001) were associated with anxiety. Bivariate relationships between anxiety and the mediator variables (benzodiazepine and psychotropic medication use, physical activity, and emotional support) were also examined. Anxiety was associated with greater benzodiazepine use (Po.001), greater psychotropic medication use (Po.001), and insufficient emotional support (Po.001). These variables were entered into a logistic regression analysis to determine their relationship with anxiety, independent of each variable. Number of comorbid conditions (odds ratio (OR) 5 1.15, 95% confidence interval (CI) 5 1.01-1.30), depressive symptoms (OR 5 4.79, 95% CI 5 3.32-6.91), benzodiazepine use (OR 5 1.98, 95% CI 5 1.15-3.40), and emotional support (OR 5 0.43, 95% CI 5 0.30-0.62) had significant relationships with anxiety independent of the other variables.
The percentage of women developing another functional difficulty over the course of the study was 63.5% for any ADL, 34.3% for mobility, 64.9% for lifting, and 29.6% for light housework. For each area of difficulty, women who expressed anxiety symptoms were more likely to report another functional difficulty in subsequent followups ( Figure 1 ).
Significant covariates in the model predicting ADL disability were age (relative risk (RR) 5 1.02, 95% CI 5 1.00-1.03) and physical performance (RR 5 0.87, 95% CI 5 0.84-0.90). Significant covariates in the model predicting mobility disability were age (RR 5 1.02, 95% CI 5 1.00- Table 2 presents the results of the Cox proportional hazards models. Model 1 consists of the unadjusted RRs of developing another functional difficulty. Anxiety was associated with a greater risk of developing difficulty with ADLs, mobility, lifting, and light housework. After adjusting for baseline differences in age, race, vision, number of diseases, physical performance, and depressive symptoms (Model 2), anxiety remained a significant predictor of developing difficulty with ADLs and light housework. The relationships between mobility difficulty and lifting difficulty were no longer significant.
Three possible mediators of the effects of anxiety on the development of disability were considered: benzodiazepine and psychotropic medication use, physical activity, and adequate emotional support. Because there was no significant relationship between anxiety and physical activity (Table  1) , physical activity was not considered in further models. Benzodiazepine and psychotropic medication use were entered into one analysis, and emotional support was entered into another regression analysis in the step containing anxiety. A variable was considered to be a mediator if it accounted for a significant proportion of the variance in disability and if it reduced the RR of anxiety by 10% or more. None of the variables met these criteria. Emotional support was not related to new onset of difficulty in any of the four areas, and the addition of benzodiazepine and psychotropic medication use was related only to new difficulty in lifting. Only benzodiazepine use was significant in this model (w 2 (3) 5 12.12, P 5.007), although it had no effect on the relationship between anxiety and disability. Thus, none of the proposed variables were significant mediators of the effect of anxiety on the progression of disability.
DISCUSSION
Anxiety symptoms are common in older adults. The results of this study indicate that 19% of the older women in the sample experienced symptoms of anxiety, consistent with findings from community surveys. 29, 30 Previous research indicates that anxiety is associated with disability, 1, 9, 10, 31 but these studies have largely employed cross-sectional designs, which limit the ability to examine anxiety as a risk factor for functional decline. This study provides evidence that anxiety is associated with the progression of disability in vulnerable older women, independent of several potential confounding factors.
A key confounding factor is the presence of depressive symptoms that are often present with anxiety. 32, 33 Depression has been identified as a risk factor for physical disability (see 34 for a review), yet the role of anxiety in the development of disability independent of depressive symptoms has not been studied. In this study, the role of anxiety as a predictor of worsening disability was examined while controlling for depression. It was found that depression was significantly related only to lifting disability. Depressive symptoms were not related to the three other types of disability. Anxiety, alternatively, remained a significant predictor of ADL and light housework disabilities. Thus, these results establish anxiety as a risk factor for the progression of disability independent of depressive symptoms.
In an effort to begin to understand the effect of anxiety on disability, three possible mediators were examined: physical activity, benzodiazepine and psychotropic medication use, and lack of emotional support. The results of this study failed to provide support for the idea that these three variables play a mediating role in the relationship between anxiety and disability. How then can the link between anxiety and the progression of disability be explained? Anxiety may be reflective of preterminal Note: Psychotropic medications include barbiturates, monamine oxidase inhibitors, selective serotonin reuptake inhibitors, serotonin and norepinephrine reuptake inhibitors, trazodone, and tricyclics, and were used on a routine or as-needed basis. Ã Defined as a score of ! 10 on the Geriatric Depression Scale.
SD 5 standard deviation. psychiatric phenomena that lead to disability, but in this sample, anxiety was not found to be related to 3-year mortality (P4.52; data not shown). Somatic symptoms of anxiety may affect functional capacity. For example, feeling dizzy or shaky could make it difficult to walk across the room and perform daily activities. Another possibility is that anxiety may precede physical diseases that cause disability. Anxiety is a risk factor for hypertension 35, 36 and heart disease, 37 both of which could result in increased disability. Anxiety may have an effect on immune dysregulation, such as by slowing down immune responses to pathogens and thereby increasing one's susceptibility to disease. 38 Nevertheless, anxiety could also lead to curtailing activity levels because of perception of risk. Finally, anxiety itself could be a confounder for other factors associated with disability but not explored here, such as impaired balance or falling. Further studies are needed to examine these and other possible mediators.
The main limitation of this paper is that the sample consists of disabled women. All participants had difficulty in at least two domains of functioning at the start of the study, but because difficulty was assessed in a number of areas and the sample was large, it was possible to examine the progression of disability in older women, which is a strength of this study. Another limitation of this study is that anxiety symptoms, rather than anxiety disorders, are assessed. A clinical interview that assesses specific anxiety disorders would be ideal. Nonetheless, the items were chosen from the well-validated Hopkins Sympton Checklist because they are key symptoms of anxiety that are characteristic of most anxiety disorders. It is impressive that it was possible to identify a group at risk for the worsening of disability using only four questions. Another strength of this study was that it was possible to examine measures of disability in multiple areas that are ecologically valid for older adults. Finally, this study examined the role of anxiety as a risk for disability while controlling for depressive symptoms.
Anxiety is a common yet understudied problem for many older adults. This study found that anxiety is prevalent and is independently associated with the progression of disability in older adults, even after statistically controlling for confounding variables. Women with anxiety symptoms were 28% to 67% more likely to demonstrate greater functional difficulty than women without anxiety. This suggests that anxiety needs to be given more attention. The results need to be followed with trials that test the effect of the treatment of anxiety on the delay or even prevention of disability.
